— Know what they know.
Not Investment Advice

VDRM OTC

ViaDerma, Inc.
1W: +100.0% 1M: +100.0% 3M: -50.0% YTD: -33.3% 1Y: +0.0% 3Y: -98.3% 5Y: -98.5%
$0.00
-0.00 (-50.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 58 · $123371 mcap · 126M float · 0.074% daily turnover · Short 84% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.1M
52W Range0.0001-0.008
Volume4,099
Avg Volume93,544
Beta0.20
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOChristopher A Otiko
Employees75
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2014-10-31
1050 E Flamingo Rd
Las Vegas, NV 89119
US
310 496 5744
About ViaDerma, Inc.

ViaDerma, Inc., a specialty pharmaceutical enterprise based in the United States, focuses on both the development and commercialization of pharmaceutical products. It also licenses its proprietary technology to other companies within the pharmaceutical sector, addressing various therapeutic areas. The company's primary offering is Vitastem, a topical antibiotic containing tetracycline, effective for treating a broad spectrum of ailments such as cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. Beyond its established products, ViaDerma is dedicated to expanding its pipeline, with ongoing development in fields including advanced topical antibiotics, antifungal treatments for toenails, diabetic amputation recovery, general acne, psoriasis, eczema, burn care, anti-aging and wrinkle-reducing formulations, medical cannabis applications, male pattern baldness, skin cancer, erectile dysfunction, and pain management. Established in 2007, the company operated as Décor Products International, Inc. until its renaming to ViaDerma, Inc. in May 2014. Its corporate operations are directed from Marina Del Rey, California.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms